Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by MINI123on Aug 23, 2021 8:10am
181 Views
Post# 33747431

Europe CBD Oil Market Share, Trends | Research Report

Europe CBD Oil Market Share, Trends | Research Report

According to the latest report by IMARC Group, titled Europe CBD Oil MarketIndustry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the europe CBD oil market to grow at a CAGR of around 23% during 2021-2026.

Cannabidiol (CBD) is a non-psychoactive compound obtained from resins, leaves, and flowers of the marijuana or hemp plant. To produce CBD oil, cannabidiol is extracted from the cannabis plant and is diluted with a carrier oil, such as coconut oil. CBD oil has a high content of amino acids, iron, fiber, zinc, etc. Besides having moderating effects on depression, anxiety, insomnia, seizures, etc., the oil is also used to relieve pain, improve heart health, alleviate cancer-related symptoms, treat acne, etc.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Europe CBD Oil Market Trends:

The increasing legalization of cannabidiol across several European countries is primarily driving the market for CBD oil. Moreover, the rising prevalence of various neurological and psychiatric disorders is also catalyzing the product demand for treating such ailments. In line with this, CBD oil-infused supplements are being increasingly adopted in cancer treatment to minimize the side effects of chemotherapy, like weight loss, nausea, fatigue, etc. Additionally, the advancing pharmaceutical industry and the increasing use of bioactive ingredients in drugs are further bolstering the product demand. Besides this, the escalating usage of CBD oil in cosmetics and personal care products due to its anti-inflammatory and anti-aging properties is expected to further strengthen the Europe CBD oil market in the coming years.

Request Free Sample Report: https://www.imarcgroup.com/europe-cbd-oil-market/requestsample

Europe CBD Oil Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Aurora Cannabis, Diamond CBD Inc., ENDOCA, APHRIA Inc., ConnOils LLC, Elixinol Global Limited, Emblem CANNABIS, NuLeaf Naturals, LLC, CBD Ultra Limited and The Original Alternative Limited.

The report has segmented the market on the basis on region, disc type, material type and end user.

Breakup by Source:

  • Marijuana Based
  • Hemp Based

Breakup by Product Type:

  • Inorganic
  • Organic

Breakup by Product Category:

  • Flavoured
  • Unflavoured

Breakup by Application:

  • Food and Beverages
  • Personal Care
  • Healthcare
  • Nutraceuticals
  • Others

Breakup by Distribution Channel:

  • Direct
  • Indirect

Breakup by Country:

  • Germany
  • Spain
  • Italy
  • France
  • United Kingdom
  • Russia
  • Rest of Europe

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/europe-cbd-oil-market

Key highlights of the report:

  • Market Performance (2015-2020)
  • Market Outlook (2021- 2026)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

<< Previous
Bullboard Posts
Next >>